PEN Q1 2021 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$169M+23.2% YoY

Gross Profit

$111M65.8% margin

Operating Income

$13M8.0% margin

Net Income

$12M7.0% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$841M

Total Liabilities

$190M

Stockholders' Equity

$655M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$169M	$137M	+23.2%
Gross Profit	$111M	$88M	+26.5%
Operating Income	$13M	$610,000	+2107.0%
Net Income	$12M	$1M	+730.6%

Revenue Segments

Peripheral Vascular

$89M53%

Neuro

$80M47%

Geographic Segments

UNITED STATES

$120M71%

Other Non-US

$49M29%